Evidence map›Paper›PMID 20068232›Full record

ReviewScience signaling2010

Basal release of ATP: an autocrine-paracrine mechanism for cell regulation.

Ross Corriden, Paul A Insel

Open access · greenAbstract readReview
In one paragraph

Review in Science signaling, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 179 papers.

0numbers the graph read from it
0cells of the map it votes in
179citing papers in PubMed
25.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

179 citing papers in PubMed, 344 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. ATP-Powered Signaling Between Artificial and Living Cells.Angewandte Chemie (International ed. in English) · 2025
    Article
  11. Article
  12. Allergen-induced activation of epithelial P2YThe Journal of allergy and clinical immunology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. A Second Drug Binding Site in P2X3.bioRxiv : the preprint server for biology · 2024
    Article
  17. Feedback facilitation by adenosine APurinergic signalling · 2024
    Article
  18. Article
  19. Article
  20. Review

119 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ross CorridenDepartments of Pharmacology and Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Paul A Insel
University of California San Diego · US

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Training Grant in GastroenterologyT32DK007202 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 1985 to 2022
$7.7M
Beta-Adrenergic Receptors of S49 Lymphoma CellsR01GM061774 · NIGMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI INSEL, PAUL A · 2002 to 2005
$1.3M
NIDDK NIH HHS T32 DK007202NIGMS NIH HHS R01 GM061774NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

Cells release adenosine triphosphate (ATP), which activates plasma membrane-localized P2X and P2Y receptors and thereby modulates cellular function in an autocrine or paracrine manner. Release of ATP and the subsequent activation of P2 receptors help establish the basal level of activation (sometimes termed "the set point") for signal transduction pathways and regulate a wide array of responses that include tissue blood flow, ion transport, cell volume regulation, neuronal signaling, and host-pathogen interactions. Basal release and autocrine or paracrine responses to ATP are multifunctional, evolutionarily conserved, and provide an economical means for the modulation of cell, tissue, and organismal biology.

Indexed as

Adenosine TriphosphateAnimalsAutocrine CommunicationBiological TransportCell SizeHumansModels, BiologicalParacrine CommunicationReceptors, Purinergic P2Receptors, Purinergic P2XReceptors, Purinergic P2Y12Adenosine TriphosphateP2RY12 protein, humanReceptors, Purinergic P2Receptors, Purinergic P2XReceptors, Purinergic P2Y12

Identifiers

PMID20068232
PMCPMC3085344
OpenAlexW2096663326

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.